Even Healthcare Raises $50 Million at $300 Million Valuation

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
Even Healthcare Raises $50 Million at $300 Million Valuation

Subscription-based healthcare firm Even Healthcare has secured $50 million in fresh equity led by Khosla Ventures. The funding values the company at $300 million as it plans to expand its hospital network in Bengaluru. Investors should note the company's rapid revenue growth alongside rising losses as it scales operations.

Detailed Coverage

Even Healthcare, a subscription-based platform that integrates health insurance with hospital and clinic services, has raised $50 million in its latest equity funding round. The investment is led by San Francisco-based Khosla Ventures, which is contributing $30 million, while existing investors are funding the remaining $20 million. This capital injection pushes the company’s valuation to approximately $300 million, a notable rise from its previous valuation of roughly $153 million reported in January 2026.

Strategic Expansion and Growth Plans

The company currently operates one hospital and two clinics in Bengaluru. With the fresh capital, management intends to scale its physical presence significantly by opening six additional hospitals by the end of 2026. This aggressive expansion strategy is a central part of the company's business model, which aims to provide members with a combined experience of primary care clinics and hospital insurance coverage. Khosla Ventures has been a consistent backer of the company, having participated in its initial $5 million seed round back in 2021 and currently holding a 10.4% stake.

Financial Performance and Operational Costs

While the company has shown strong top-line growth, its financial statements reflect the high costs associated with scaling a healthcare delivery network. In the fiscal year 2025, Even Healthcare reported revenue of ₹27.2 crore, up from ₹8.3 crore in the previous fiscal year. However, this growth has come with increased financial pressure. The company reported a net loss of ₹90.2 crore for FY25, compared to a loss of ₹72.4 crore in FY24. For investors, the balance between expanding the hospital footprint and managing these operating losses will be a primary factor to watch as the company moves toward its 2026 expansion targets.

Market Context and Future Monitoring

The Indian healthcare sector is currently seeing increased interest in integrated models that combine insurance with service delivery. Industry projections suggest the health insurance market could grow at a compound annual rate of 12.8% through 2028. Even Healthcare’s subscription model aims to tap into this trend by focusing on both inpatient and outpatient services. Going forward, the most important updates for those interested in the company’s progress will include the actual timeline of the six new hospital launches and the company’s ability to improve its profit margins while maintaining its current pace of revenue growth.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.